On cross-priming of MHC class I-specific CTL: Rule or exception?

European Journal of Immunology

Volumn 32, Issue 9, 2002, Pages 2385-2392

  Zinkernagel, Rolf M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CD8+ cell; Cross priming; CTL; Dendritic cell; MHC class I

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; CD8 ANTIGEN; CELL PROTEIN; CONCANAVALIN A; HEPATITIS B SURFACE ANTIGEN; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MINOR HISTOCOMPATIBILITY ANTIGEN; OVALBUMIN; RAS PROTEIN; TUMOR ANTIGEN; VIRUS ANTIGEN; VIRUS NUCLEOPROTEIN;

ANALYTIC METHOD; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BYSTANDER EFFECT; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS TOLERANCE; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HELPER CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TUMOR CELL; VIRUS PARTICLE;

ANIMALS; ANIMALS, CONGENIC; ANTIGEN PRESENTATION; ANTIGENS; ANTIGENS, NEOPLASM; ANTIGENS, VIRAL; DENDRITIC CELLS; H-2 ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNE TOLERANCE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MINOR HISTOCOMPATIBILITY ANTIGENS; MODELS, IMMUNOLOGICAL; OVALBUMIN; PEPTIDES; RATS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036737779     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200209)32:9<2385::AID-IMMU2385>3.0.CO;2-V     Document Type: Article

References (69)

1. + T cells. Crit. Rev. Immunol, 1996, 16: 359-379.
2. Vogt, A. B., Arndt, S. O., Hammerling, G. J., and Kropshofer, H., Quality control of MHC class II associated peptides by HLA-DM/H2-M. Semin. Immunol, 1999. 11: 391-403.
3. Swain, S. L., T cell subsets and the recognition of MHC class. Immunol. Rev. 1983, 74: 129-142.
4. Germain, R. N., T cell development and the CD4-CD8 lineage decision. Nat. Immunol. Rev. 2002. 2: 309-322.
5. Bevan, M. J., Antigen recognition. Class discrimination in the world of immunology. Nature 1987. 325: 192-194.
6. Bevan, M. J., Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 1976. 143: 1283-1288.
7. Rock, K. L., A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 1996. 17: 131-137.
8. Carbone, F. R., Kurts, C., Bennett, S. R., Miller, J. F., and Heath, W. R., Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol. Today 1998. 19: 368-373.
9. Steinman, R. M., Turley, S., Mellman, I., and Inaba, K., The induction of tolerance by dendritic cells that have captured apoptotic cells. J. Exp. Med. 2000. 191: 411-416.
10. Heath, W. R. and Carbone, F. R., Cross-presentation in viral immunity and self-tolerance. Nat. Immunol. Rev. 2001. 1: 126-132.
11. Lanzavecchia, A., Immunology. Licence to kill [news; comment]. Nature 1998. 393: 413-414.
12. Pardoll, D., T cells and tumours. Nature 2001. 411: 1010-1012.
13. Albert, M. L. and Bhardwaj, N., Resurrecting the dead: DCs cross-present antigen derived from apoptotic cells on MHC I. The Immunologist 1998. 6: 194.
14. Sotomayor, E. M., Borrello, I., Rattis, F. M., Cuenca, A. G., Abrams, J., Staveley-O'Carroll, K., and Levitsky, H. I., Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T cell tolerance during B cell lymphoma progression. Blood 2001. 98: 1070-1077.
15. Rodriguez, A., Regnault, A., Kleijmeer, M., Ricciardi-Castagnoli, P., and Amigorena, S., Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells. Nat. Cell. Biol. 1999. 1: 362-368.
16. Bretscher, P. and Cohn, M., A theory of self-nonself discrimination. Science 1970. 169: 1042-1049.
17. Lafferty, K. J. and Cunningham, A. J., A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 1975. 53: 27-42.
18. Mueller, D. L., Jenkins, M. K., and Schwartz, R. H., Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 1989. 7: 445-480
19. Matzinger, P., Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994. 12: 991-1045.
20. Simpson, E. and Gordon, R. D., Responsiveness to HY antigen Ir gene complementation and target cell specificity. Immunol. Rev. 1977. 35: 59-75.
21. von Boehmer, H., Haas, W., and Jerne, N. K., Major histocompatibility complex-linked immune-responsiveness is acquired by lymphocytes of low-responder mice differentiating in thymus of high-responder mice. Proc. Natl. Acad. Sci. USA 1978. 75: 2439-2442.
22. Pilarski, L. M., Antigen-specific helper T cells are essential for cytotoxic T cell responses to metabolically inactivated stimulator cells. Eur. J. Immunol. 1979. 9: 454-460.
23. Meruelo, D., Relationship between leukemia virus genomes and histocompatibility genes. Year. Immunol. 1985. 163-170.
24. Speiser, D. E., Schneider, R., Hengartner, H., MacDonald, H. R., and Zinkernagel, R. M., Clonal deletion of self-reactive T cells in irradiation bone marrow chimeras and neonatally tolerant mice. Evidence for intercellular transfer of Mlsa. J. Exp. Med. 1989. 170: 595-600.
25. Pilarski, L. M., Bretscher, P. A., and Baum, L. L., Helper T cells are required for the polyclonal stimulation of cytotoxic T cells by concanavalin A. J. Exp. Med 1977. 145: 1237-1249.
26. Bevan, M. J., Killer cells reactive to altered-self antigens can also be alloreactive. Proc. Natl. Acad. Sci. USA 1977. 74: 2094-2098.
27. Matzinger, P. and Bevan, M. J., Induction of H-2-restricted cytotoxic T cells: in. vivo induction has the appearance of being unrestricted. Cell. Immunol. 1977. 33: 92-100.
28. Hunig, T. and Bevan, M. J., Specificity of T cell cones illustrates altered self hypothesis. Nature 1981. 294: 460-462.
29. Zinkernagel, R. M., Uncertainties - Discrepancies in Immunology. Immunol. Rev. 2002, in press.
30. Kovacsovics-Bankowski, M., Clark, K., Benacerraf, B., and Rock, K. L., Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 1993. 90: 4942-4946.
31. Kovacsovics-Bankowski, M. and Rock, K. L., A phagosometo-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995. 267: 243-246.
32. Moore, M. W., Carbone, F. R., and Bevan, M. J., Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 1988. 54: 777-785.
33. Amigorena, S., Fc gamma receptors and cross-presentation in dendritic cells. J. Exp. Med. 2002. 195: F1-F3.
34. Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., and Amigorena, S., Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 1998. 4: 594-600.
35. Huang, A. Y., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., and Levitsky, H., Role of bone marrow-derived cells in presenting MHC class I- restricted tumor antigens. Science 1994. 264: 961-965.
36. Lu, Z., Yuan, L., Zhou, X., Sotomayor, E., Levitsky, H. I., and Pardoll, D. M., CD40-independent pathways of T cell help for priming of CD8(+) cytotoxic T lymphocytes. J. Exp. Med. 2000. 191: 541-550.
37. Toes, R. E., Blom, R. J., van, d., V, Offringa, R., Melief, C. J., and Kast, W. M., Protective antitumor immunity induced by immunization with completely allogeneic tumor cells. Cancer Res. 1996. 56: 3782-3787.
38. Toes, R. E., Ossendorp, F., Offringa, R., and Melief, C. J., CD4 T cells and their role in antitumor immune responses. J. Exp. Med. 1999. 189: 753-756.
39. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., and Melief, C. J., T cell help for cytotoxic T lymphocytes is mediated by CD40- CD40L interactions. Nature 1998. 393: 480-483.
40. Kurts, C., Heath, W. R., Carbone, F. R., Allison, J., Miller, J. F. A. P., and Kosaka, H., Constitutive class I-restricted exogenous presentation of self antigens in. vivo. J. Exp. Med. 1996. 184: 923-930.
41. Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., and Heath, W. R., Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J. Exp. Med. 1997. 186: 239-245.
42. Kurts, C., Miller, J. F., Subramaniam, R. M., Carbone, F. R., and Heath, W. R., Major histocompatibility complex class I-restricted cross- presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 1998. 188: 409-414.
43. + T cell help. J. Exp. Med. 1997. 186: 65-70.
44. Bennett, S. R., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F., and Heath, W. R., Help for cytotoxic-T cell responses is mediated by CD40 signaling. Nature 1998. 393: 478-480.
45. Albert, M. L., Sauter, B., and Bhardwaj, N., Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTL. Nature 1998. 392: 86-89.
46. Mandl, S., Sigal, L. J., Rock, K. L., and Andino, R., Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen. Proc. Natl. Acad. Sci. USA 1998. 95: 8216-8221.
47. Schirmbeck, R., Melber, K., and Reimann, J., Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 1995. 25: 1063-1070.
48. Bachmann, M. F., Kündig, T. M., Freer, G., Li, Y., Kang, C. Y., Bishop, D. H., Hengartner, H., and Zinkernagel, R. M., Induction of protective cytotoxic T cells with viral proteins. Eur. J. Immunol. 1994. 24: 2228-2236.
49. Storni, T., Lechner, F., Erdmann, I., Bachi, T., Jegerlehner, A., Dumrese, T., Kundig, T. M., Ruedl, C., and Bachmann, M. F., Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles. J. Immunol. 2002. 168: 2880-2886.
50. Hino, T., Ishikawa, H., and Saito, K., Cytotoxic T lymphocyte response to minor H-43a alloantigen in H-43b mice. Privileged H-2Kb restriction to the response is not due to immunodominance or epistatic effect but due to Ir gene function of H- 2Kb itself. J. Immunol. 1988. 140: 44-51.
51. Speiser, D. E., Zurcher, T., Ramseier, H., Hengartner, H., Staeheli, P., Haller, O., and Zinkernagel, R. M., Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. Proc. Natl. Acad. Sci. USA 1990. 87: 2021-2025.
52. Kundig, T. M., Bachmann, M. F., DiPaolo, C., Simard, J. J., Battegay, M., Lother, H., Gessner, A., Kuhlcke, K., Ohashi, P. S., and Hengartner, H., Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 1995. 268: 1343-1347.
53. Ochsenbein, A. F., Sierro, S., Odermatt, B., Pericin, M., Karrer, U., Hermans J., Hemmi, S., Hengartner, H., and Zinkernagel, R. M., Roles of tumour localization, second signals and cross priming in cytotoxic T cell induction. Nature 2001. 411: 1058-1064.
54. Cayeux, S., Richter, G., Becker, C., Pezzutto, A., Dorken, B., and Blankenstein, T., Direct and indirect T cell priming by dendritic cell vaccines. Eur. J. Immunol. 1999. 29: 225-234.
55. Buseyne, F., Le Gall, S., Boccaccio, C., Abastado, J. P., Lifson, J. D., Arthur, L. O., Riviere, Y., Heard, J. M., and Schwartz, O., MHC-I-restricted presentation of HIV-1 virion antigens without viral replication. Nat. Med. 2001. 7: 344-349.
56. von Boehmer, H., Hengartner, H., Nabholz, M., Lernhardt, W., Schreier, M. H., and Haas, W., Fine specificity of a continuously growing killer cell clone specific for H-Y antigen. Eur. J. Immunol. 1979. 9: 592-597.
57. Speiser, D. E., Kyburz, D., Stubi, U., Hengartner, H., and Zinkernagel, R. M., Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. J. Immunol. 1992. 149: 972-980.
58. + T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor. J. Immunol. 2000. 164: 3902-3912.
59. Ronchetti, A., Rovere, P., Iezzi, G., Galati, G., Heltai, S., Protti, M. P., Garancini, M. P., Manfredi, A. A., Rugarli, C., and Bellone, M., Immunogenicity of apoptotic cells in. vivo: role of antigen load, antigen-presenting cells, and cytokines. J. Immunol, 1999. 163: 130-136.
60. Buller, R. M., Holmes, K. L., Hugin, A., Frederickson, T. N., and Morse, H. C., III, Induction of cytotoxic T cell responses in. vivo in the absence of CD4 helper cells. Nature 1987. 328: 77-79.
61. Biddison, W. E., Sharrow, S. O., and Shearer, G. M., T cell sub-populations required for the human cytotoxic T lymphocyte response to influenza virus: evidence for T cell help. J. Immunol. 1981. 127: 487-491.
62. Sarvetnick, N., Shizuru, J., Liggitt, D., Martin, L., McIntyre, B., Gregory, A., Parslow, T., and Stewart, T., Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. Nature 1990. 346: 844-847.
63. + T cells to cause immunopathology. J. Exp. Med. 1998. 187: 763-774.
64. Welsh, R. M., McNally, J. M., Brehm, M. A., and Selin, L. K., Consequences of cross-reactive and bystander CTL responses during viral infections. Virology 2000. 270: 4-8.
65. Wraith, D. C. and Askonas, B. A., Induction of influenza A virus cross-reactive cytotoxic T cells by a nucleoprotein/haemagglutinin preparation. J. Gen. Virol 1985. 66 (Pt 6): 1327-1331.
66. Stitz, L., Schmitz, C., Binder, D., Zinkernagel, R. M., Paoletti, E., and Becht, H., Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection. J. Gen. Virol. 1990. 71: 1169-1179.
67. Timmerman, J. M., Czerwinski, D. K., Davis, T. A., Hsu, F. J., Benike, C., Hao, Z. M., Taidi, B., Rajapaksa, R., Caspar, C. B.,Okada, C. Y., van Beckhoven, A., Liles, T. M., Engleman, E. G. and Levy, R., Idiotype-pulsed dendritic cell vaccination for B cell lymphoma: clinical and immune responses in 35 patients. Blood 2002. 99: 1517-1526.
68. Jerne, N. K., Towards a network theory of the immune system. Ann. Immunol. (Paris) 1974. 125C: 373-389.
69. Lindenmann, J., Speculations on idiotypes and homobodies. Ann. Immunol. (Paris) 1973. 124: 171-184.